Alnylam Pharmaceuticals shares owned by Capital Research and Management Company - Division 3
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Capital Research and Management Company - Division 3
from 13F filings
Historical chart of Capital Research and Management Company - Division 3 investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by Capital Research and Management Company - Division 3 consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by Capital Research and Management Company - Division 3
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $246k | 550 | 447.85 |
| 2024-12-31 | $334M | 1.4M | 235.33 |
| 2024-09-30 | $1.1B | 4.0M | 275.03 |
| 2024-03-31 | $546M | 3.7M | 149.45 |
| 2023-12-31 | $687M | 3.6M | 191.44 |
| 2023-09-30 | $549M | 3.1M | 177.10 |
| 2023-06-30 | $547M | 2.9M | 189.94 |
| 2023-03-31 | $447M | 2.2M | 200.32 |
| 2022-12-31 | $477M | 2.0M | 237.65 |
More positions owned by Capital Research and Management Company - Division 3
View all positions for Capital Research and Management Company - Division 3